Last reviewed · How we verify

ABI injection — Competitive Intelligence Brief

ABI injection (ABI injection) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Cardiac ablation agent. Area: Cardiovascular.

phase 3 Cardiac ablation agent Cardiovascular Biologic Live · refreshed every 30 min

Target snapshot

ABI injection (ABI injection) — Istanbul Training and Research Hospital. ABI injection is used to treat atrial fibrillation by ablating the heart tissue causing the arrhythmia.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
ABI injection TARGET ABI injection Istanbul Training and Research Hospital phase 3 Cardiac ablation agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Cardiac ablation agent class)

  1. Istanbul Training and Research Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). ABI injection — Competitive Intelligence Brief. https://druglandscape.com/ci/abi-injection. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: